BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:31 PM
 | 
Dec 12, 2011
 |  BC Extra  |  Company News

Panel vote tips in Alexza's favor

FDA's Psychopharmacologic Drugs Advisory Committee voted 9-8, with one abstention, in favor of recommending approval of inhaled Adasuve loxapine from Alexza Pharmaceuticals Inc. (NASDAQ:ALXA) to treat agitation in patients with schizophrenia or bipolar disorder. The panel specified that its recommendation is only for...

Read the full 201 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >